Arca
Skip to content
Tools
Tools

Myalgia

Drug research and approvals for myalgia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 55 studies of myalgia are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 55
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 55 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

30 approved, 4 in phase 3, 11 in phase 2; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Diclofenac, Flurbiprofen, Ibuprofen, Indomethacin, Ketoprofen, Meclofenamic acid, Naproxen, Piroxicam, Tolmetin, Lidocaine, Bendazac, Nimesulide, Phenylbutazone, Feprazone, Bufexamac, Oxyphenbutazone anhydrous, Suxibuzone, Tolazoline, Cyclobenzaprine, Menthol, Capsaicin, Aspirin, Methyl salicylate, Dimethyl sulfoxide, Benzydamine, Dexketoprofen, Aceclofenac, Esflurbiprofen, Loxoprofen, Felbinac

Suxamethonium
Phase 3 Muscle-type nicotinic acetylcholine receptor agonist
Rocuronium
Phase 3 Muscle-type nicotinic acetylcholine receptor antagonist
Zucapsaicin
Phase 3 Vanilloid receptor agonist
Baricitinib
Phase 2 Tyrosine-protein kinase JAK1 inhibitor
Duloxetine
Phase 2 Serotonin transporter inhibitor
Selenium
Phase 2
Fentiazac
Phase 2
Nifenazone
Phase 2

How Its Trials Ended

262 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 37 whose ending is known, 51% met their primary endpoint, 5% missed it and 43% stopped early.

  • Completed, result not reported15358%
  • Ongoing4015%
  • Status unknown3212%
  • Met its primary endpoint197%
  • Stopped: other or unclear93%
  • Stopped: enrollment or feasibility31%
  • Stopped: funding31%
  • Missed its primary endpoint21%
  • Stopped: sponsor or business decision10%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.